EAM
ANIK icon

Eagle Asset Management’s Anika Therapeutics ANIK Stock Holding History

Eagle Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,195
Closed -$54K – 596
2020
Q4 		$54K Buy
+1,195
New +$45.4K ﹤0.01% 540
2015
Q3 		– Sell
-122,812
Closed -$4.06M – 643
2015
Q2 		$4.06M Buy
122,812
+24,853
+25% +$886K 0.02% 469
2015
Q1 		$4.03M Buy
97,959
+925
+1% +$37.4K 0.02% 454
2014
Q4 		$3.95M Sell
97,034
-2,108
-2% -$82.4K 0.02% 460
2014
Q3 		$3.63M Buy
+99,142
New +$4.28M 0.02% 487

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Eagle Asset Management's ANIK Position: Q1 2021 in Review

Eagle Asset Management sold out of Anika Therapeutics (ANIK) in Q1 2021, closing a stake of 1,195 shares — an estimated $54K sold.

Eagle Asset Management first reported a position in ANIK in Q3 2014 and held it in 5 quarters. The position peaked at $4.06M in Q2 2015. 145 funds tracked by Wall St. Rank hold ANIK as of Q1 2021.

  • Eagle Asset Management reported no remaining Anika Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Eagle Asset Management sold 1,195 Anika Therapeutics shares in Q1 2021, an estimated $54K.
  • Eagle Asset Management first reported a position in Anika Therapeutics in Q3 2014 and held it in 5 quarters.
  • Eagle Asset Management's Anika Therapeutics position peaked at $4.06M in Q2 2015.
  • 145 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2021.

Based on Eagle Asset Management's 13F filing for Q1 2021, filed 14 May 2021.